Merck & Co., Inc. (MRK) reporting calendar
Merck & Co., Inc. files periodic reports with the SEC as MRK on NYSE. Atlas tracks 33 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 17 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 4 May 2026
- Reports on record
- 33
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open MRK market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 4 May 2026 | 34 days | 0001628280-26-029802 |
| 10-K | 31 Dec 2025 | 24 Feb 2026 | 55 days | 0000310158-26-000063 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0000310158-25-000059 |
| 10-Q | 30 Jun 2025 | 5 Aug 2025 | 36 days | 0000310158-25-000014 |
| 10-Q | 31 Mar 2025 | 2 May 2025 | 32 days | 0001628280-25-021834 |
| 10-K | 31 Dec 2024 | 25 Feb 2025 | 56 days | 0001628280-25-007732 |
| 10-Q | 30 Sep 2024 | 6 Nov 2024 | 37 days | 0001628280-24-045689 |
| 10-Q | 30 Jun 2024 | 5 Aug 2024 | 36 days | 0001628280-24-034715 |
| 10-Q | 31 Mar 2024 | 3 May 2024 | 33 days | 0001628280-24-020283 |
| 10-K | 31 Dec 2023 | 26 Feb 2024 | 57 days | 0001628280-24-006850 |
| 10-Q | 30 Sep 2023 | 3 Nov 2023 | 34 days | 0001628280-23-036717 |
| 10-Q | 30 Jun 2023 | 7 Aug 2023 | 38 days | 0001628280-23-027770 |
| 10-Q | 31 Mar 2023 | 5 May 2023 | 35 days | 0001628280-23-015990 |
| 10-K | 31 Dec 2022 | 24 Feb 2023 | 55 days | 0001628280-23-005061 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0000310158-22-000034 |
| 10-Q | 30 Jun 2022 | 5 Aug 2022 | 36 days | 0000310158-22-000030 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0000310158-22-000011 |
| 10-K | 31 Dec 2021 | 25 Feb 2022 | 56 days | 0000310158-22-000003 |
| 10-Q | 30 Sep 2021 | 5 Nov 2021 | 36 days | 0000310158-21-000032 |
| 10-Q | 30 Jun 2021 | 9 Aug 2021 | 40 days | 0000310158-21-000028 |
| 10-Q | 31 Mar 2021 | 5 May 2021 | 35 days | 0000310158-21-000009 |
| 10-K | 31 Dec 2020 | 25 Feb 2021 | 56 days | 0000310158-21-000004 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0000310158-20-000030 |
| 10-Q | 30 Jun 2020 | 5 Aug 2020 | 36 days | 0000310158-20-000026 |
| 10-Q | 31 Mar 2020 | 6 May 2020 | 36 days | 0000310158-20-000009 |
| 10-K | 31 Dec 2019 | 26 Feb 2020 | 57 days | 0000310158-20-000005 |
| 10-Q | 30 Sep 2019 | 5 Nov 2019 | 36 days | 0000310158-19-000042 |
| 10-Q | 30 Jun 2019 | 6 Aug 2019 | 37 days | 0000310158-19-000037 |
| 10-Q | 31 Mar 2019 | 8 May 2019 | 38 days | 0000310158-19-000019 |
| 10-K | 31 Dec 2018 | 27 Feb 2019 | 58 days | 0000310158-19-000014 |
| 10-Q | 30 Sep 2018 | 6 Nov 2018 | 37 days | 0000310158-18-000039 |
| 10-Q | 30 Jun 2018 | 7 Aug 2018 | 38 days | 0000310158-18-000034 |
| 10-Q | 31 Mar 2018 | 8 May 2018 | 38 days | 0000310158-18-000011 |
Source: SEC EDGAR company submissions for CIK 0000310158. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.